NCT06154356Recruiting
Action Observation and Motor Imagery Therapy in Parkinson's Disease
Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind. The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 23 Nov 2023
- Start date
- 14 Dec 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Karamanoğlu Mehmetbey University
- Diseases
- Parkinson disease
- NCT number
- NCT06154356
What you commit to
- Study type: Interventional
- Planned participants: 54
- From 14 Dec 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with uncontrolled hypertension and diabetes mellitus
- Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
- Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
Other
- Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
- Patients with severe hearing problems
- Patients with severe vision problems
- Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
Who the study is looking for
- Patients with a diagnosis of Parkinson's Disease
- Hoehn and Yahr Stage 1-3
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karaman Training and Research Hospital Coordinator of this site? Confirm its status | Karaman | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.